中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2014年
28期
18-18,20
,共2页
贝那普利%厄贝沙坦%原发性高血压%室性心律失常
貝那普利%阨貝沙坦%原髮性高血壓%室性心律失常
패나보리%액패사탄%원발성고혈압%실성심률실상
Benazepril%Irbesartan%Essential hypertension%Ventricular arrhythmia
目的：比较厄贝沙坦与贝那普利对高血压患者室性心律失常的影响。方法：2010年1月-2013年9月收治高血压合并室性心律失常患者80例，按照随机数字表法分为治疗组和对照组，各40例，治疗组给予厄贝沙坦进行治疗，对照组给予贝那普利，比较两种药物对高血压合并室性心律失常患者血压及室性心律失常发生情况的影响。结果：治疗后，两组患者的收缩压和舒张压均显著低于治疗前，差异均有统计学意义(P＜0.05)。但是治疗后两组的收缩压、舒张压差异无统计学意义(P＞0.05)。结果表明，在治疗高血压合并室性心律失常的患者时厄贝沙坦与贝那普利的降压效果相似。结论：厄贝沙坦治疗高血压患者室性心律失常，不仅能够有效控制血压，而且能够降低室性心律失常的发生，不良反应少，应该在临床治疗中广泛推广。
目的：比較阨貝沙坦與貝那普利對高血壓患者室性心律失常的影響。方法：2010年1月-2013年9月收治高血壓閤併室性心律失常患者80例，按照隨機數字錶法分為治療組和對照組，各40例，治療組給予阨貝沙坦進行治療，對照組給予貝那普利，比較兩種藥物對高血壓閤併室性心律失常患者血壓及室性心律失常髮生情況的影響。結果：治療後，兩組患者的收縮壓和舒張壓均顯著低于治療前，差異均有統計學意義(P＜0.05)。但是治療後兩組的收縮壓、舒張壓差異無統計學意義(P＞0.05)。結果錶明，在治療高血壓閤併室性心律失常的患者時阨貝沙坦與貝那普利的降壓效果相似。結論：阨貝沙坦治療高血壓患者室性心律失常，不僅能夠有效控製血壓，而且能夠降低室性心律失常的髮生，不良反應少，應該在臨床治療中廣汎推廣。
목적：비교액패사탄여패나보리대고혈압환자실성심률실상적영향。방법：2010년1월-2013년9월수치고혈압합병실성심률실상환자80례，안조수궤수자표법분위치료조화대조조，각40례，치료조급여액패사탄진행치료，대조조급여패나보리，비교량충약물대고혈압합병실성심률실상환자혈압급실성심률실상발생정황적영향。결과：치료후，량조환자적수축압화서장압균현저저우치료전，차이균유통계학의의(P＜0.05)。단시치료후량조적수축압、서장압차이무통계학의의(P＞0.05)。결과표명，재치료고혈압합병실성심률실상적환자시액패사탄여패나보리적강압효과상사。결론：액패사탄치료고혈압환자실성심률실상，불부능구유효공제혈압，이차능구강저실성심률실상적발생，불량반응소，응해재림상치료중엄범추엄。
Objective:To compare the effects of irbesartan and benazepril in the treatment of hypertensive patients with ventricular arrhythmias.Methods:80 hypertension patients complicated with ventricular arrhythmia were selected from January 2010 to September 2013.They were randomly divided into the treatment group and the control group with 40 cases in each. Patients in two groups were treated with irbesartan and benazepril respectively,we then compared the difference between two kinds of drugs in the incidence of blood pressure and ventricular arrhythmia among hypertension patients with ventricular arrhythmias.Results:After treatment,systolic and diastolic blood pressure in two groups both were significantly lower than that before the treatment,and the differences were statistically significant (P<0.05).But the differences in systolic pressure and diastolic pressure after treatment were no statistically significant between two groups(P>0.05).This showed that the hypotensive effect of irbesartan and benazepril was similar in hypertensive patients with ventricular arrhythmias.Conclusion:Irbesartan applied in the treatment of hypertensive patients with ventricular arrhythmias not only can control the blood pressure effectively,but also can effectively reduce the occurrence of ventricular arrhythmia,and less adverse reaction,so it is worthy of promotion.
